We are live on ! Find out more
DS

DRW Securities Portfolio holdings

AUM $7.21B
1-Year Est. Return 20.54%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+20.54%
3 Year Est. Return
+87.88%
5 Year Est. Return
+88.87%
10 Year Est. Return
+277.95%
AUM
$1.64B
AUM Growth
+$82.8M
Cap. Flow
+$66.1M
Cap. Flow %
4.04%
Top 10 Hldgs %
95.34%
Holding
198
New
36
Increased
37
Reduced
16
Closed
99

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$322M
2
GLD icon
SPDR Gold Trust
GLD
+$30.1M
3
FXI icon
iShares China Large-Cap ETF
FXI
+$17.9M
4
INDA icon
iShares MSCI India ETF
INDA
+$16.2M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$4.82M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$44.5M
2
BND icon
Vanguard Total Bond Market
BND
+$16.8M
3
EWT icon
iShares MSCI Taiwan ETF
EWT
+$10.2M
4
EZA icon
iShares MSCI South Africa ETF
EZA
+$6.8M
5
MCHI icon
iShares MSCI China ETF
MCHI
+$6.45M

Sector Composition

Rank Sector Weight
1 Healthcare 0.49%
2 Real Estate 0.02%
3 Financials 0.02%
4 Consumer Staples 0.01%
5 Consumer Discretionary 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUPH icon
76
Aurinia Pharmaceuticals
AUPH
$1.97B
$176K 0.01%
31,300
– –
KALV
77
DELISTED
KalVista Pharmaceuticals
KALV
$167K 0.01%
20,600
+5,600
+37% +$49.4K
LRMR icon
78
Larimar Therapeutics
LRMR
$416M
$164K 0.01%
1,333
+416
+45% +$35.3K
GYRE icon
79
Gyre Therapeutics
GYRE
$662M
$152K 0.01%
+1,733
New +$304K
OVID icon
80
Ovid Therapeutics
OVID
$435M
$143K 0.01%
18,317
+3,000
+20% +$25.8K
ALDX icon
81
Aldeyra Therapeutics
ALDX
$91.7M
$135K 0.01%
17,000
+5,000
+42% +$39.9K
CVG
82
CALL
DELISTED
Convergys
CVG
$132K 0.01%
+5,400
New +$129K
ELDN icon
83
Eledon Pharmaceuticals
ELDN
$276M
$129K 0.01%
1,027
+166
+19% +$17.2K
EPIX
84
DELISTED
ESSA Pharma
EPIX
$128K 0.01%
+33,857
New +$127K
VBIV
85
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$126K 0.01%
+1,530
New +$148K
OMED
86
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$124K 0.01%
53,740
– –
DBRG icon
87
CALL
DigitalBridge
DBRG
$2.94B
$115K 0.01%
+4,625
New +$111K
AIXC
88
AIxCrypto Holdings Inc
AIXC
$16.6M
$111K 0.01%
3
+1
+50% +$37K
SNDX icon
89
Syndax Pharmaceuticals
SNDX
$1.84B
$105K 0.01%
+15,000
New +$147K
PDSB icon
90
PDS Biotechnology
PDSB
$38.1M
$103K 0.01%
5,001
+2,500
+100% +$52.2K
OTIC
91
DELISTED
Otonomy, Inc.
OTIC
$96K 0.01%
25,000
+10,000
+67% +$41.6K
RGLS
92
DELISTED
Regulus Therapeutics
RGLS
$89K 0.01%
1,125
– –
TNXP icon
93
Tonix Pharmaceuticals
TNXP
$157M
– –
0
– –
NBRV
94
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$87K 0.01%
100
+16
+19% +$18.3K
CHMA
95
DELISTED
Chiasma, Inc. Common Stock
CHMA
$86K 0.01%
57,000
– –
TRAW icon
96
Traws Pharma
TRAW
$7.43M
$61K ﹤0.01%
+27
New +$78.4K
PHIO icon
97
Phio Pharmaceuticals
PHIO
$12.1M
$37K ﹤0.01%
3
– –
AGRX
98
DELISTED
Agile Therapeutics
AGRX
$19K ﹤0.01%
+19
New +$66.7K
CRIS icon
99
Curis
CRIS
$9.53M
$17K ﹤0.01%
25
– –
ACGL icon
100
Arch Capital
ACGL
$36.1B
– –
-13,005
Closed -$371K
2 3
4
5 6

Similar funds

CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

DRW Securities's Q2 2018 Portfolio in Review

As of Q2 2018, DRW Securities held 198 positions worth $1.64B, up 5.3% from $1.55B the previous quarter. Its ten largest holdings account for 95% of the portfolio.

DRW Securities deployed $66.1M of net new capital in Q2 2018, opening 36 new positions and adding to 37 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 40,335 shares worth $4.91M.

By sector, the portfolio is most concentrated in Healthcare at 0.49% of assets, down from 0.51% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $44.5M trimmed.

  • DRW Securities's largest Q2 2018 buy was iShares 20+ Year Treasury Bond ETF: 40,335 shares worth $4.91M.
  • DRW Securities added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $322M increase.
  • DRW Securities's biggest Q2 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $44.5M.
  • DRW Securities fully exited Vanguard Total Bond Market in Q2 2018, selling an estimated $16.8M.
  • DRW Securities's ten largest holdings make up 95% of its $1.64B portfolio in Q2 2018.
  • DRW Securities opened 36 new positions and closed 99 in Q2 2018.
  • DRW Securities's portfolio value rose 5.3% quarter-over-quarter to $1.64B.

Based on DRW Securities's 13F filing for Q2 2018, filed 14 Aug 2018.